Repository logo
 
Publication

Stability of extemporaneously prepared captopril oral liquid formulation for paediatric patients

dc.contributor.authorCaetano, Liliana Aranha
dc.contributor.authorGato, Sara
dc.contributor.authorAlmeida, T.
dc.contributor.authorCheong, F.
dc.contributor.authorGraça, Anabela
dc.date.accessioned2012-12-18T11:34:05Z
dc.date.available2012-12-18T11:34:05Z
dc.date.issued2010-04
dc.description.abstractCaptopril, an inhibitor of angiotensin converting enzyme (ACE), is used to treat medical conditions like hypertension and heart failure, and it is usually administered in tablet form for adults. Since this dosage form is not recommended for infants and children up to 6 years, hospital pharmacies have to prepare liquid formulations for oral administration of captopril. Traditionally, concentration of captopril used in the formulations is 1mg/ml. The problem is that captopril is prone to oxidation, and its stability in solution is affected by pH, concentration of captopril, the presence of oxygen or metal ions. The influence of different formulation ingredients on the properties of physical and chemical stability of captopril in liquid preparations has been evaluated. Main of the study: to evaluate the stability of captopril for 30 days when formulated in a 1 mg/ml suspension adjuvanted with citric acid.por
dc.identifier.citationCaetano LA, Gato S, Almeida T, Cheong F, Graça A. Stability of extemporaneously prepared captopril oral liquid formulation for paediatric patients. In Congresso Internacional das Ciências e Tecnologias da Saúde, Ilha Terceira (Acores), 29 de Abril-1 de Maio. Poster.por
dc.identifier.urihttp://hdl.handle.net/10400.21/1994
dc.language.isoengen
dc.peerreviewedyespor
dc.publisherEscola Superior de Tecnologia da Saúde de Lisboapor
dc.subjectFarmáciapor
dc.subjectFarmacologiapor
dc.subjectCaptoprilpor
dc.subjectPediatriapor
dc.subjectFórmula líquidapor
dc.titleStability of extemporaneously prepared captopril oral liquid formulation for paediatric patientspor
dc.typeconference object
dspace.entity.typePublication
rcaap.rightsopenAccesspor
rcaap.typeconferenceObjectpor

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Stability of extemporaneously prepared captopril oral liquid formulation.pdf
Size:
4.44 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections